Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 63502

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
October 11, 2012
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Vintage Pharmaceuticals LLC DBA Qualitest Pharmaceuticals

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Perphenazine Tablets, USP, 8 mg, 100-count tablets per bottle, Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, NDC 0603-5092-21.

D-010-2013
Recall number
D-010-2013
Initiated
October 11, 2012
Classification
Class II
Status
Terminated
Quantity
2,755 bottles

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0
Tablet Separation: Possibility of cracked or split coating on the tablets.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Tablet Separation: Possibility of cracked or split coating on the tablets.

Code information

Lot C1130511A, Exp 5/13

Distribution pattern

Nationwide and Puerto Rico